Tobias Heintges

发表

Hermansky-Pudlak syndrome.

H. Scharnagl, J. Bax, M. Eszlinger, 2001, European journal of dermatology : EJD.

Impact of BRAF and RAS mutations on first-line efficacy of FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab: analysis of the FIRE-3 (AIO KRK-0306) study.

A. Kiani, S. Al-Batran, T. Kirchner, 2017, European journal of cancer.